Journal of Literature Pharmacy Sciences

Depresyonun Önlenmesi ve Tedavisinde Demir, Çinko, Bakır ve Magnezyumun Rolü
The Role of Iron, Zinc, Copper and Magnesium in the Prevention and Treatment of Depression
Şevval Zeynep TUĞTEPEa, Bilge KOÇa
aBahçeşehir Üniversitesi Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü, İstanbul, TÜRKİYE
J Lit Pharm Sci. 2020;9(1):101-8
doi: 10.5336/pharmsci.2019-70103
Article Language: TR
Full Text
ÖZET
 Depresyon, dünya üzerinde 300 milyondan fazla kişide görülmekte olan yaygın bir duygudurum bozukluğu olarak bilinmektedir. Depresyonun oluşum sebepleri genetik özellikler veya çevresel özelliklerden kaynaklı olabilir. En önemli çevresel faktörlerden biri ise beslenme durumudur. Sosyoekonomik durum, çeşitli psikolojik etmenler, kronik hastalıklar, gebelik, postpartum, menopoz, stres faktörleri, uyku düzeni gibi birçok etkenin yanı sıra; yetersiz veya dengesiz bir beslenme alışkanlığı, kafein tüketim seviyesi vb. beslenmeye bağlı etmenler depresyon belirtilerinin oluşumunda önemli rol oynar. Öte yandan, vitamin ve mineraller başta olmak üzere belli başlı besin ögesi eksikliklerinin giderilmesi, depresyonun önlenmesini veya oluşumundan sonra tedavisini sağlayabilir. Beslenmeye bağlı etmenler arasında üzerine en fazla araştırılma yapılan konulardan biri mikronütrient eksiklikleridir. Hem vitamin hem de mineral eksiklikleri nörolojik yolakları ve nörolojik fonksiyonları etkileyen en önemli faktörler arasında bulunmaktadır. Bu sebeple, vitamin ve minerallerin depresyonun önlenmesi ve tedavisinde görev alabileceği düşünülmektedir. Bu alanda, özellikle mineraller konusunda oldukça fazla araştırma ve klinik çalışma yapılmış bulunmakta; ancak hâlâ kesin bir kanıya varabilmek için daha fazla veriye ihtiyaç duyulmaktadır. Minerallerin nörolojik fonksiyonlar ve bu seviyede görev alan enzimler üzerindeki önemli etkisi günümüze dek birçok çalışmada ortaya konulmuştur. Bu çalışmada, çeşitli veri tabanları taranmış ve demir, çinko, bakır ve magnezyum elementlerinin depresyonun önlenmesindeki ve depresyon tedavisindeki rollerini araştıran yayınlar incelenmiştir.

Anahtar Kelimeler: Depresyon; demir; çinko; bakır; magnezyum
ABSTRACT
 Depression is a common mood disorder seen in over 300 million people worldwide. Causes of depression may be caused by genetic factors or environmental factors. Nutritional status is one of the most important environmental factors. In addition to many factors such as socioeconomic status, various psychological factors, chronic diseases, pregnancy, postpartum, menopause, stress factors, sleep patterns; nutrition-related factors such as inadequate or unbalanced nutritional habits, caffeine consumption levels and so on, play an important role in the development of depression symptoms. On the other hand, the elimination of certain nutrient deficiencies, especially vitamins and minerals, can prevent the development of or help treating depression. Among the factors related to nutrition, one of the most investigated subjects is micronutrient deficiencies. Both vitamin and mineral deficiencies are among the most important factors affecting neurological pathways and neurological functions. Therefore, it is thought that vitamins and minerals might be involved in the prevention and treatment of depression. Many researches and clinical studies have been done in this area, especially on minerals; however, there is still a need for more data to reach a definitive conclusion. The important effect of minerals on neurological functions and enzymes involved in this level has been demonstrated in many studies. In this review, various databases were scanned and publications investigating the roles of iron, zinc, copper and magnesium elements in the prevention of depression and the treatment of depression are examined.

Keywords: Depression; iron; zinc; copper; magnesium
REFERENCES:
  1. Reynolds CF 3rd, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, et al. Maintenance treatment of major depression in old age. N Engl J Med. 2006;354(11):1130-8. [Crossref]  [PubMed] 
  2. Wells KB, Hays RD, Burnam MA, Rogers W, Greenfield S, Ware JE Jr. Detection of depressive disorder for patients receiving prepaid or fee-for-service care: results from the Medical Outcomes Study. JAMA. 1989;262(23):3298-302. [Crossref]  [PubMed] 
  3. Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90. [Crossref]  [PubMed]  [PMC] 
  4. World Health Organization. Public health round-up. Bull World Health Organ. 2017;95(4):244-5. [Crossref]  [PubMed]  [PMC] 
  5. Rao TS, Asha MR, Ramesh BN, Rao KS. Understanding nutrition, depression and mental illnesses. Indian J Psychiatry. 2008;50(2):77-82. [Crossref]  [PubMed]  [PMC] 
  6. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547. [Crossref]  [PubMed]  [PMC] 
  7. Rebar AL, Stanton R, Geard D, Short C, Duncan MJ, Vandelanotte C. A meta-meta-analysis of the effect of physical activity on depression and anxiety in non-clinical adult populations. Health Psychol Rev. 2015;9(3):366-78. [Crossref]  [PubMed] 
  8. Li F, Liu X, Zhang D. Fish consumption and risk of depression: a meta-analysis. J Epidemiol Community Health. 2016;70(3):299-304. [Crossref]  [PubMed] 
  9. Wang L, Shen X, Wu Y, Zhang D. Coffee and caffeine consumption and depression: a meta-analysis of observational studies. Aust N Z J Psychiatry. 2016;50(3):228-42. [Crossref]  [PubMed] 
  10. Yokoyama Y, Kitamura A, Yoshizaki T, Nishi M, Seino S, Taniguchi Y, et al. Score-based and nutrient-derived dietary patterns are associated with depressive symptoms in community-dwellingolder Japanese: a cross-sectional study. J Nutr Health Aging. 2019;23(9):896-903. [Crossref]  [PubMed] 
  11. Eby GA 3rd, Eby KL. Magnesium for treatment-resistant depression: a review and hypothesis. Med Hypotheses. 2010;74(4):649-60. [Crossref]  [PubMed] 
  12. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996;19(2):179-200. [Crossref] 
  13. Dusek P, Jankovic J, Le W. Iron dysregulation in movement disorders. Neurobiol Dis. 2012;46(1):1-18. [Crossref]  [PubMed] 
  14. Heninger GR, Delgado PL, Charney DS. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry. 1996;29(1):2-11. [Crossref]  [PubMed] 
  15. Sobolevskii AI, Khodorov BI. Blocker studies of the functional architecture of the NMDA receptor channel. Neurosci Behav Physiol. 2002;32(2):157-71. [Crossref]  [PubMed] 
  16. Khedr E, Hamed SA, Elbeih E, El-Shereef H, Ahmad Y, Ahmed S. Iron states and cognitive abilities in young adults: neuropsychological and neurophysiological assessment. Eur Arch Psychiatry Clin Neurosci. 2008;258(8):489-96. [Crossref]  [PubMed] 
  17. Li Z, Li B, Song X, Zhang D. Dietary zinc and iron intake and risk of depression: a meta-analysis. Psychiatry Res. 2017;251:41-7. [Crossref]  [PubMed] 
  18. Baune BT, Neuhauser H, Ellert U, Berger K. The role of the inflammatory markers ferritin, transferrin and fibrinogen in the relationship between major depression and cardiovascular disorders-The German Health Interview and Examination Survey. Acta Psychiatr Scand. 2010;121(2):135-42. [Crossref]  [PubMed] 
  19. Yi S, Nanri A, Poudel-Tandukar K, Nonaka D, Matsushita Y, Hori A, et al. Association between serum ferritin concentrations and depressive symptoms in Japanese municipal employees. Psychiatry Res. 2011;189(3):368-72. [Crossref]  [PubMed] 
  20. Stelzhammer V, Haenisch F, Chan MK, Cooper JD, Steiner J, Steeb H, et al. Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients. Int J Neuropsychopharmacol. 2014;17(10):1599-608. [Crossref]  [PubMed] 
  21. Lever-van Milligen BA, Vogelzangs N, Smit JH, Penninx BW. Hemoglobin levels in persons with depressive and/or anxiety disorders. J Psychosom Res. 2014;76(4):317-21. [Crossref]  [PubMed] 
  22. Korkmaz S, Yıldız S, Korucu T, Gundogan B, Sunbul ZE, Korkmaz H, et al. Frequency of anemia in chronic psychiatry patients. Neuropsychiatr Dis Treat. 2015;11:2737-41. [Crossref]  [PubMed]  [PMC] 
  23. Lomagno KA, Hu F, Riddell LJ, Booth AO, Szymlek-Gay EA, Nowson CA, et al. Increasing iron and zinc in pre-menopausal women and its effects on mood and cognition: a systematic review. Nutrients. 2014;6(11):5117-41. [Crossref]  [PubMed]  [PMC] 
  24. Kathlen ML, Escott SS. Krause's Food Nutrition and Diet Therapy. 10th ed. Philadelphia: Chapman & Hall; 2004. p.132.
  25. Shafi M, Taufiq F, Mehmood H, Afsar S, Badar A. Relation between depressive disorder and iron deficiency anemia among adults reporting to a secondary healthcare facility: a hospital-based case control study. J Coll Physicians Surg Pak. 2018;28(6):456-9. [Crossref]  [PubMed] 
  26. Pamuk GE, Uyanik MS, Top MS, Tapan U, Ak R, Uyanik V. Gastrointestinal symptoms are closely associated with depression in iron deficiency anemia: a comparative study. Ann Saudi Med. 2015;35(1):31-5. [Crossref]  [PubMed]  [PMC] 
  27. Murat S, Ali U, Serdal K, Süleyman D, İlknur P, Mehmet S, et al. Assessment of subjective sleep quality in iron deficiency anaemia. Afr Health Sci. 2015;15(2):621-7. [Crossref]  [PubMed]  [PMC] 
  28. Hidese S, Saito K, Asano S, Kunugi H. Association between iron‐deficiency anemia and depression: a web‐based Japanese investigation. Psychiatry Clin Neurosci. 2018;72(7):513-21. [Crossref]  [PubMed] 
  29. Li Z, Wang W, Xin X, Song X, Zhang D. Association of total zinc, iron, copper and selenium intakes with depression in the US adults. J Affect Disord. 2018;228:68-74. [Crossref]  [PubMed] 
  30. Dziembowska I, Kwapisz J, Izdebski P, Żekanowska E. Mild iron deficiency may affect female endurance and behavior. Physiol Behav. 2019;205:44-50. [Crossref]  [PubMed] 
  31. Joe P, Getz M, Redman S, Petrilli M, Kranz TM, Ahmad S, et al. Serum zinc levels in acute psychiatric patients: a case series. Psychiatry Res. 2018;261:344-50. [Crossref]  [PubMed] 
  32. Ghasemi A, Zahediasl S, Hosseini-Esfahani F, Azizi F. Reference values for serum zinc concentration and prevalence of zinc deficiency in adult Iranian subjects. Biol Trace Elem Res. 2012;149(3):307-14. [Crossref]  [PubMed] 
  33. Maret W. Zinc biochemistry: from a single zinc enzyme to a key element of life. Adv Nutr. 2013;4(1):82-91. [Crossref]  [PubMed]  [PMC] 
  34. Bitanihirwe BK, Cunningham MG. Zinc: the brain's dark horse. Synapse. 2009;63(11):1029-49. [Crossref]  [PubMed] 
  35. Hambidge M. Human zinc deficiency. J Nutr. 2000;130(5S Suppl):1344S-9S. [Crossref]  [PubMed] 
  36. Szewczyk B, Kubera M, Nowak G. The role of zinc in neurodegenerative inflammatory pathways in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(3):693-701. [Crossref]  [PubMed] 
  37. Scheiber I, Dringen R, Mercer JF. Copper: effects of deficiency and overload. In: Sigel A, Sigel H, Sigel RKO, eds. Interrelations Between Essential Metal Ions and Human Diseases. 1st ed. Dordrecht: Springer; 2013. p.359-87. [Crossref] 
  38. Gonoodi K, Moslem A, Ahmadnezhad M, Darroudi S, Mazloum Z, Tayefi M, et al. Relationship of dietary and serum zinc with depression score in Iranian adolescent girls. Biol Trace Elem Res. 2018;186(1):91-7. [Crossref]  [PubMed] 
  39. Wang J, Um P, Dickerman B, Liu J. Zinc, magnesium, selenium and depression: a review of the evidence, potential mechanisms and implications. Nutrients. 2018;10(5):584. [Crossref]  [PubMed]  [PMC] 
  40. Ranjbar E, Kasaei MS, Mohammad-Shirazi M, Nasrollahzadeh J, Rashidkhani B, Shams J, et al. Effects of zinc supplementation in patients with major depression: a randomized clinical trial. Iran J Psychiatry. 2013;8(2):73-9.
  41. Tahmasebi K, Amani R, Nazari Z, Ahmadi K, Moazzen S, Mostafavi SA. Association of mood disorders with serum zinc concentrations in adolescent female students. Biol Trace Elem Res. 2017;178(2):180-8. [Crossref]  [PubMed] 
  42. Swardfager W, Herrmann N, Mazereeuw G, Goldberger K, Harimoto T, Lanctôt KL. Zinc in depression: a meta-analysis. Biol Psychiatry. 2013;74(12):872-8. [Crossref]  [PubMed] 
  43. Dickerman B, Liu J. Do the micronutrients zinc and magnesium play a role in adult depression? Top Clin Nutr. 2011;26(3):257-67. [Crossref]  [PubMed]  [PMC] 
  44. Russo AJ. Analysis of plasma zinc and copper concentration, and perceived symptoms, in individuals with depression, post zinc and anti-oxidant therapy. Nutr Metab Insights. 2011;4:19-27. [Crossref]  [PubMed]  [PMC] 
  45. Dale E, Bang-Andersen B, Sánchez C. Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs. Biochem Pharmacol. 2015;95(2):81-97. [Crossref]  [PubMed] 
  46. Wapnir RA. Copper absorption and bioavailability. Am J Clin Nutr. 1998;67(5 Suppl):1054-60. [Crossref]  [PubMed] 
  47. Choi BS, Zheng W. Copper transport to the brain by the blood-brain barrier and blood-CSF barrier. Brain Res. 2009;1248:14-21. [Crossref]  [PubMed]  [PMC] 
  48. Scheiber IF, Mercer JF, Dringen R. Metabolism and functions of copper in brain. Prog Neurobiol. 2014;116:33-57. [Crossref]  [PubMed] 
  49. Collins JF, Prohaska JR, Knutson MD. Metabolic crossroads of iron and copper. Nutr Rev. 2010;68(3):133-47. [Crossref]  [PubMed]  [PMC] 
  50. Młyniec K, Gaweł M, Doboszewska U, Starowicz G, Pytka K, Davies CL, et al. Essential elements in depression and anxiety. Part II. Pharmacol Rep. 2015;67(2):187-94. [Crossref]  [PubMed] 
  51. Ni M, You Y, Chen J, Zhang L. Copper in depressive disorder: a systematic review and meta-analysis of observational studies. Psychiatry Res. 2018;267:506-15. [Crossref]  [PubMed] 
  52. Kim TH, Choi JY, Lee HH, Park Y. Associations between dietary pattern and depression in Korean adolescent girls. J Pediatr Adolesc Gynecol. 2015;28(6):533-7. [Crossref]  [PubMed] 
  53. Kamath SU, Chaturvedi A, Yerrapragada DB, Kundapura N, Amin N, Devaramane V. Increased levels of acetylcholinesterase, paraoxonase 1, and copper in patients with moderate depression-a preliminary study. Rep Biochem Mol Biol. 2019;7(2):174.
  54. Gaetke LM, Chow-Johnson HS, Chow CK. Copper: toxicological relevance and mechanisms. Arch Toxicol. 2014;88(11):1929-38. [Crossref]  [PubMed]  [PMC] 
  55. de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1-46. [Crossref]  [PubMed] 
  56. Serefko A, Szopa A, Wlaź P, Nowak G, Radziwoń-Zaleska M, Skalski M, et al. Magnesium in depression. Pharmacol Rep. 2013;65(3):547-54. [Crossref] 
  57. Murck H. Magnesium and affective disorders. Nutr Neurosci. 2002;5(6):375-89. [Crossref]  [PubMed] 
  58. Boyle NB, Lawton C, Dye L. The effects of magnesium supplementation on subjective anxiety and stress-a systematic review. Nutrients. 2017;9(5):429. [Crossref]  [PubMed]  [PMC] 
  59. Cubała WJ, Landowski J, Dziadziuszko M, Chrzanowska A, Wielgomas B. Magnesium, C-reactive protein, and cortisol in drug-naïve patients with short illness-duration, first episode major depressive disorder: possible immunomodulatory role for magnesium. Magnes Res. 2016;29(4):169-74. [Crossref]  [PubMed] 
  60. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171-86. [Crossref]  [PubMed] 
  61. Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol Psychol. 2001;57(1-3):141-52. [Crossref] 
  62. Pochwat B, Sowa-Kucma M, Kotarska K, Misztak P, Nowak G, Szewczyk B. Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway. Psychopharmacology (Berl). 2015;232(2):355-67. [Crossref]  [PubMed]  [PMC] 
  63. Jacka FN, Overland S, Stewart R, Tell GS, Bjelland I, Mykletun A. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. Aust N Z J Psychiatry. 2009;43(1):45-52. [Crossref]  [PubMed] 
  64. Sun C, Wang R, Li Z, Zhang D. Dietary magnesium intake and risk of depression. J Affect Disord. 2019;246:627-32. [Crossref]  [PubMed] 
  65. Tarleton EK, Littenberg B, MacLean CD, Kennedy AG, Daley C. Role of magnesium supplementation in the treatment of depression: a randomized clinical trial. PLoS One. 2017;12(6):e0180067. [Crossref]  [PubMed]  [PMC] 
  66. Martínez-González MÁ, Sánchez-Villegas A. Magnesium intake and depression: the SUN cohort. Magnes Res. 2016;29(3):102-11.
  67. Yary T, Lehto SM, Tolmunen T, Tuomainen TP, Kauhanen J, Voutilainen S, et al. Dietary magnesium intake and the incidence of depression: a 20-year follow-up study. J Affect Disord. 2016;193:94-8. [Crossref]  [PubMed] 
  68. Tarleton EK, Kennedy AG, Rose GL, Crocker A, Littenberg B. The association between serum magnesium levels and depression in an adult primary care population. Nutrients. 2019;11(7):1475. [Crossref]  [PubMed]  [PMC] 
  69. Nakamura M, Miura A, Nagahata T, Shibata Y, Okada E, Ojima T. Low zinc, copper, and manganese intake is associated with depression and anxiety symptoms in the japanese working population: findings from the eating habit and well-being study. Nutrients. 2019;11(4):847. [Crossref]  [PubMed]  [PMC] 
  70. Twayej AJ, Al-Hakeim HK, Al-Dujaili AH, Maes M. Lowered zinc and copper levels in drug-naïve patients with major depression: effects of antidepressants, ketoprofen and immune activation. World J Biol Psychiatry. 2019;1-12. [Crossref]  [PubMed] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com